ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1935

Timely Referral of Patients with Inflammatory Rheumatic Diseases to Rheumatology: Validation of a Referral Algorithm with Frontline Physicians

Nelly Ziade1, Karen Mechleb2, Nizar Ani3, avin maroof4, ASAL ADNAN RIDHA5, Manal El Rakawi6, Chafika Haouichat6, Bassel Elzorkany7, Sherif Gamal8, Mariama Erraoui9, Manal Al-Mashaleh10, Fatima Alnaimat11, Basel masri12, fatemah Baron13, Lina El Kibbi14, Krystel Aouad15 and Ihsane Hmamouchi16, and ARCH - ArLAR, 1Saint-Joseph University, Beirut, Lebanon, 2Saint Joseph University Beirut, Beirut, Lebanon, 3Baghdad College of Medicine, Baghdad, Iraq, 4University of Kurdistan Hawler, Erbil, Iraq, 5Baghdad Teaching Hospital, baghdad, Iraq, 6Djillali Bounaama University Hospital, Algiers, Algeria, 7Private (BZRC), Cairo, Egypt, 8Cairo University, Cairo, Egypt, 9Souss Massa Univeristy, Rabat, Morocco, 10Royal Medical Services, Amman, Jordan, 11University of Jordan, Amman, Jordan, 12Jordan Hospital and Medical Center, Amman, Jordan, 13Al-Jahra Hospital, Ministry of Health, Kuwait, Kuwait, 14Specialized Medical Center, Riyadh, Saudi Arabia, 15Saint George Hospital University Medical Center, Beirut, Lebanon, 16Rheumatology Unit, Lalla Aicha Temara Hospital, Temara, Rabat, Morocco

Meeting: ACR Convergence 2024

Keywords: Education, Psoriatic arthritis, rheumatoid arthritis, spondyloarthritis, Work Force

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Health Services Research – ACR/ARP Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Early referral of patients with chronic inflammatory rheumatic diseases (CIRDs) to rheumatology is essential to reduce diagnostic delays and improve long-term prognosis. Referral strategies were published but might not be universally applicable. The objective of this study was to design and validate a referral algorithm for CIRDs in the Arab countries and to identify the gaps in determining the correct referral parameters.

Methods: A task force of 16 rheumatologists from 8 Arab countries reviewed available referral studies for CIRDs and adopted referral algorithms for axial spondyloarthritis, rheumatoid arthritis, and psoriasis arthritis based on the presence of local validation studies. local epidemiology and healthcare systems. The task force developed educational material (EM: video and PDF) explaining the algorithms (Figure 1) and their parameters and created five illustrative clinical vignettes (3 where primary care physicians (PCP) should refer to rheumatology and 2 where they should not). PCPs were invited using mass e-mails and social media advertisements to complete the clinical vignettes using an online survey at baseline (pre-test). Two weeks later, the EM was e-mailed to the physicians so they could complete the same clinical vignettes again (post-test). The primary outcome was the change of correct referrals per case after accessing the EM. The secondary outcome was the change in the proportion of correct parameters per case after accessing the EM. Data was presented descriptively per case, and a comparison between the pre-and post-tests was performed using the paired t-test or McNemar’s test. 

Results: A total of 901 participants from 13 Arab countries completed the pre-test and 202 the post-test. Participants’ average age was 42.1±12.1 years, and 53.5% were women. The participants included general practitioners (36.9%), internists (15.2%), orthopedic surgeons (11.9%), family physicians (6.6%), neurosurgeons (1.5%), and other specialties (16.3%). The pre-test correct referrals were high (68%, 72%, and 82%) for cases 1, 4, and 5 that needed a referral and low (24% and 21%) for cases 2 and 3 that did not need a referral (Figure 2 and 3). In the post-test phase, the correct referrals changed to 75%, 73%, and 78% for cases 1, 4, and 5 and 38% and 23% for cases 2 and 3,  with a statistically significant difference for case 2 only (p=0.0078). The proportion of correct parameters improved for all cases (p< 0.0001) in the post-test phase, and parameters with poor performance were identified.

Conclusion: Optimal referral strategies for CIRDs were adopted. The correct referral to rheumatology was high at baseline for cases that actually needed referral but low for those that did not. There was a trend towards improvement in referral with audiovisual EM, but the difference was not statistically significant for most cases. Nevertheless, the proportion of correct parameters improved significantly with EM, which will help shape the implementation of future referral campaigns.

Supporting image 1

Figure 1. Referral algorithms for patients with chronic inflammatory diseases to rheumatology adopted by the ARCH task force

Supporting image 2

Figure 2. Correct referrals in the pre- and post-test (after audiovisual educational material) phases

Supporting image 3

Figure 3. Referral patterns by primary care physicians (left panel: cases 1, 4, and 5: do need a referral to rheumatology, right panel: cases 2 and 3: do not need a referral)


Disclosures: N. Ziade: AbbVie/Abbott, 1, 6, Celgene, 5, Eli Lilly, 5, 6, Gilead, 5, Janssen, 5, 6, Pfizer, 5, 6, Roche, 1, 6; K. Mechleb: None; N. Ani: None; a. maroof: None; A. RIDHA: None; M. El Rakawi: None; C. Haouichat: None; B. Elzorkany: None; S. Gamal: None; M. Erraoui: None; M. Al-Mashaleh: None; F. Alnaimat: None; B. masri: None; f. Baron: None; L. El Kibbi: None; K. Aouad: None; I. Hmamouchi: None.

To cite this abstract in AMA style:

Ziade N, Mechleb K, Ani N, maroof a, RIDHA A, El Rakawi M, Haouichat C, Elzorkany B, Gamal S, Erraoui M, Al-Mashaleh M, Alnaimat F, masri B, Baron f, El Kibbi L, Aouad K, Hmamouchi I. Timely Referral of Patients with Inflammatory Rheumatic Diseases to Rheumatology: Validation of a Referral Algorithm with Frontline Physicians [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/timely-referral-of-patients-with-inflammatory-rheumatic-diseases-to-rheumatology-validation-of-a-referral-algorithm-with-frontline-physicians/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/timely-referral-of-patients-with-inflammatory-rheumatic-diseases-to-rheumatology-validation-of-a-referral-algorithm-with-frontline-physicians/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology